|
1
|
Prince M, Comas-Herrera A, Knapp M,
Guerchet M and Karagiannidou M: World Alzheimer Report 2016 -
Improving healthcare for people living with dementia: Coverage,
quality and costs now and in the future. Alzheimer's Disease
International; London:
|
|
2
|
Salmon DP: Neuropsychological features of
mild cognitive impairment and preclinical Alzheimer's disease. Curr
Top Behav Neurosci. 10:187–212. 2012. View Article : Google Scholar
|
|
3
|
Förstl H and Kurz A: Clinical features of
Alzheimer's disease. Eur Arch Psychiatry Clin Neurosci.
249:288–290. 1999. View Article : Google Scholar
|
|
4
|
Cong L and Jia J: Promoter polymorphisms
which regulate ADAM9 transcription are protective against sporadic
Alzheimer's disease. Neurobiol Aging. 32:54–62. 2011. View Article : Google Scholar
|
|
5
|
Tong Z, Zhang J, Luo W, Wang W, Li F, Li
H, Luo H, Lu J, Zhou J, Wan Y, et al: Urine formaldehyde level is
inversely correlated to mini mental state examination scores in
senile dementia. Neurobiol Aging. 32:31–41. 2011. View Article : Google Scholar
|
|
6
|
Tong Z, Han C, Luo W, Wang X, Li H, Luo H,
Zhou J, Qi J and He R: Accumulated hippocampal formaldehyde induces
age-dependent memory decline. Age (Dordr). 35:583–596. 2013.
View Article : Google Scholar
|
|
7
|
He R, Lu J and Miao J: Formaldehyde
stress. Sci China Life Sci. 53:1399–1404. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhang X and Poo MM: Progress in neural
plasticity. Sci China Life Sci. 53:322–329. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Luo Z: Synapse formation and remodeling.
Sci China Life Sci. 53:315–321. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhang M, Zhao Z, He L and Wan C: A
meta-analysis of oxidative stress markers in schizophrenia. Sci
China Life Sci. 53:112–124. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Sun P, Zhang Q, Han J, Tian Y and Zhang J:
TLR4 signaling induced TLR2 expression in the process of mimic
cerebral ischemia/reperfusion in vitro. Sci China Life Sci.
53:223–228. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Perry EK, Perry RH, Tomlinson BE, Blessed
G and Gibson PH: Coenzyme A-acetylating enzymes in Alzheimer's
disease: Possible cholinergic 'compartment' of pyruvate
dehydrogenase. Neurosci Lett. 18:105–110. 1980. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Gibson GE, Sheu KF, Blass JP, Baker A,
Carlson KC, Harding B and Perrino P: Reduced activities of
thiamine-dependent enzymes in the brains and peripheral tissues of
patients with Alzheimer's disease. Arch Neurol. 45:836–840. 1988.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Hirai K, Aliev G, Nunomura A, Fujioka H,
Russell RL, Atwood CS, Johnson AB, Kress Y, Vinters HV, Tabaton M,
et al: Mitochondrial abnormalities in Alzheimer's disease. J
Neurosci. 21:3017–3023. 2001.PubMed/NCBI
|
|
15
|
Sims NR, Finegan JM, Blass JP, Bowen DM
and Neary D: Mitochondrial function in brain tissue in primary
degenerative dementia. Brain Res. 436:30–38. 1987. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Eckert A, Keil U, Marques CA, Bonert A,
Frey C, Schüssel K and Müller WE: Mitochondrial dysfunction,
apoptotic cell death, and Alzheimer's disease. Biochem Pharmacol.
66:1627–1634. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Parks JK, Smith TS, Trimmer PA, Bennett JP
Jr and Parker WD Jr: Neurotoxic Abeta peptides increase oxidative
stress in vivo through NMDA-receptor and nitric-oxide-synthase
mechanisms, and inhibit complex IV activity and induce a
mitochondrial permeability transition in vitro. J Neurochem.
76:1050–1056. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Hauptmann S, Scherping I, Dröse S, Brandt
U, Schulz KL, Jendrach M, Leuner K, Eckert A and Müller WE:
Mitochondrial dysfunction: An early event in Alzheimer pathology
accumulates with age in AD transgenic mice. Neurobiol Aging.
30:1574–1586. 2009. View Article : Google Scholar
|
|
19
|
Cucchiara B and Kasner SE: Use of statins
in CNS disorders. J Neurol Sci. 187:81–89. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Simons M, Schwärzler F, Lütjohann D, von
Bergmann K, Beyreuther K, Dichgans J, Wormstall H, Hartmann T and
Schulz JB: Treatment with simvastatin in normocholesterolemic
patients with Alzheimer's disease: A 26-week randomized,
placebo-controlled, double-blind trial. Ann Neurol. 52:346–350.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Tong XK, Lecrux C, Rosa-Neto P and Hamel
E: Age-dependent rescue by simvastatin of Alzheimer's disease
cerebrovascular and memory deficits. J Neurosci. 32:4705–4715.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Tong XK, Nicolakakis N, Fernandes P,
Ongali B, Brouillette J, Quirion R and Hamel E: Simvastatin
improves cerebrovascular function and counters soluble
amyloid-beta, inflammation and oxidative stress in aged APP mice.
Neurobiol Dis. 35:406–414. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Chuang SC, Liao HJ, Li CJ, Wang GJ, Chang
JK and Ho ML: Simvastatin enhances human osteoblast proliferation
involved in mitochondrial energy generation. Eur J Pharmacol.
714:74–82. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhao XH, Xu ZR, Zhang Q and Yang YM:
Simvastatin protects human osteosarcoma cells from oxidative
stress-induced apoptosis through mitochondrial-mediated signaling.
Mol Med Rep. 5:483–488. 2012.
|
|
25
|
Xu MF, Xiong YY, Liu JK, Qian JJ, Zhu L
and Gao J: Asiatic acid, a pentacyclic triterpene in Centella
asiatica, attenuates glutamate-induced cognitive deficits in mice
and apoptosis in SH-SY5Y cells. Acta Pharmacol Sin. 33:578–587.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Piqué M, Barragán M, Dalmau M, Bellosillo
B, Pons G and Gil J: Aspirin induces apoptosis through
mitochondrial cytochrome c release. FEBS Lett. 480:193–196. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Danial NN and Korsmeyer SJ: Cell death:
Critical control points. Cell. 116:205–219. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zamzami N, Marchetti P, Castedo M,
Decaudin D, Macho A, Hirsch T, Susin SA, Petit PX, Mignotte B and
Kroemer G: Sequential reduction of mitochondrial transmembrane
potential and generation of reactive oxygen species in early
programmed cell death. J Exp Med. 182:367–377. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
St-Pierre J, Drori S, Uldry M, Silvaggi
JM, Rhee J, Jäger S, Handschin C, Zheng K, Lin J, Yang W, et al:
Suppression of reactive oxygen species and neurodegeneration by the
PGC-1 transcriptional coactivators. Cell. 127:397–408. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Mei Z, Yan P, Situ B, Mou Y and Liu P:
Cryptotanshinione inhibits β-amyloid aggregation and protects
damage from β-amyloid in SH-SY5Y cells. Neurochem Res. 37:622–628.
2012. View Article : Google Scholar
|
|
31
|
Ma L and Li W: Emodin inhibits LOVO
colorectal cancer cell proliferation via the regulation of the
Bcl-2/Bax ratio and cytochrome c. Exp Ther Med. 8:1225–1228. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Ricci JE, Gottlieb RA and Green DR:
Caspase-mediated loss of mitochondrial function and generation of
reactive oxygen species during apoptosis. J Cell Biol. 160:65–75.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Camilleri A, Zarb C, Caruana M, Ostermeier
U, Ghio S, Högen T, Schmidt F, Giese A and Vassallo N:
Mitochondrial membrane permeabilisation by amyloid aggregates and
protection by polyphenols. Biochim Biophys Acta. 1828:2532–2543.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Wang X, Wang W, Li L, Perry G, Lee HG and
Zhu X: Oxidative stress and mitochondrial dysfunction in
Alzheimer's disease. Biochim Biophys Acta. 1842:1240–1247. 2014.
View Article : Google Scholar
|
|
35
|
Santos RX, Correia SC, Wang X, Perry G,
Smith MA, Moreira PI and Zhu X: Alzheimer's disease: Diverse
aspects of mitochondrial malfunctioning. Int J Clin Exp Pathol.
3:570–581. 2010.PubMed/NCBI
|
|
36
|
García-Escudero V, Martín-Maestro P, Perry
G and Avila J: Deconstructing mitochondrial dysfunction in
Alzheimer disease. Oxid Med Cell Longev. 2013:1621522013.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Swerdlow RH, Burns JM and Khan SM: The
Alzheimer's disease mitochondrial cascade hypothesis: Progress and
perspectives. Biochim Biophys Acta. 1842:1219–1231. 2014.
View Article : Google Scholar :
|
|
38
|
Cadonic C, Sabbir MG and Albensi BC:
Mechanisms of mitochondrial dysfunction in Alzheimer's disease. Mol
Neurobiol. 53:6078–6090. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Rhein V, Song X, Wiesner A, Ittner LM,
Baysang G, Meier F, Ozmen L, Bluethmann H, Dröse S, Brandt U, et
al: Amyloid-β and tau synergistically impair the oxidative
phosphorylation system in triple transgenic Alzheimer's disease
mice. Proc Natl Acad Sci USA. 106:20057–20062. 2009. View Article : Google Scholar
|
|
40
|
Gottlieb E, Armour SM, Harris MH and
Thompson CB: Mitochondrial membrane potential regulates matrix
configuration and cytochrome c release during apoptosis. Cell Death
Differ. 10:709–717. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Hansson Petersen CA, Alikhani N, Behbahani
H, Wiehager B, Pavlov PF, Alafuzoff I, Leinonen V, Ito A, Winblad
B, Glaser E, et al: The amyloid beta-peptide is imported into
mitochondria via the TOM import machinery and localized to
mitochondrial cristae. Proc Natl Acad Sci USA. 105:13145–13150.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Picone P, Nuzzo D, Caruana L, Scafidi V
and Di Carlo M: Mitochondrial dysfunction: Different routes to
Alzheimer's disease therapy. Oxid Med Cell Longev. 2014:7801792014.
View Article : Google Scholar : PubMed/NCBI
|
